Showing 1 - 1 of 1
This study focuses on the stock market effects associated with the announcements of product approvals, denials and recalls by the US Food and Drug Administration (FDA), and the impact of product approvals on research and development expenditures (R&D) and forecasts of earnings by Value Line....
Persistent link: https://www.econbiz.de/10009275860